Replies to post #28853 on Ariad Pharmaceuticals Inc fka ARIA

[ariadndndough]

Jaybe nice find. Keep them coming

[glass_half_full]

summary of NCCN guidelines

I thought that this piece:

Ponatinib (Iclusig®)
• Third-generation, pan-BCR-ABL TKI
– Inhibits VEGFR, FGFR, PDGFR, FGFR, EPH, and SRC kinases, KIT, RET, TIE2, and FLT3

was of interest -- honestly, I haven't even heard of EPH or TIE2, unless they're referred to in some other way. Frankly, that's kind of a long list!